People might attribute midnight bouts of chest pain or waves of nausea to food poisoning, stress or a stubborn case of indigestion, but Rutgers Health researchers suggest that knowing your family's ...

The FDA on Wednesday granted accelerated approval to zanidatamab (Ziihera), a bispecific antibody, for pretreated HER2-positive biliary tract cancer. Approval stipulates use in unresectable or ...

Credit: Jazz Pharmaceuticals Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor. Findings showed the ORR was 52% (95% CI, 39-65), of which ...

Biliary atresia (BA) is a rare, progressive inflammatory disease of the biliary system that is the leading cause of neonatal cholestasis, characterised by fibrosis and obliteration of the bile ducts.

SAN FRANCISCO ― Adding the checkpoint inhibitor durvalumab (Imfinzi) to chemotherapy significantly improved overall survival in patients with advanced biliary tract cancer, as compared to chemotherapy ...

The presentation entitled “Targeting HER2 mutation-positive advanced biliary tract cancers with neratinib: Final results from the phase 2 SUMMIT ‘basket’ trial” was presented at the Gastrointestinal ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved durvalumab with gemcitabine and cisplatin for adults with locally advanced or metastatic ...

A Danish cohort study found higher levels of the inflammation marker SCD163 were associated with lower quality of life in primary biliary cholangitis patients. When Patients with Primary Sclerosing ...

Bile duct cysts are atypical enlargements that develop within your biliary system. They may disrupt the normal flow of bile from the gallbladder and liver to your small intestine. Bile duct growths ...

The biliary tract cancer market is experiencing steady growth driven by rising global incidence and improved diagnostic capabilities. Increasing adoption of targeted therapies and immuno-oncology ...

Biliary tract cancer is increasing in incidence and mortality across Europe, with more people under the age of 60 years old now impacted by the disease. However, despite this, knowledge about these ...